跳至主要内容
临床试验/NCT01375725
NCT01375725已完成不适用

Mobius PT-INR Accuracy Clinical Study

Universal Biosensors Pty Ltd1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2010年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
1
主要终点
PT/INR values from the experimental device will be statistically correlated to results obtained from a commercially available device

研究概览

简要总结

The purpose of this study is to measure prothrombin time (PT) expressed in International Normalised Ratio (INR) units in persons receiving coumadin (warfarin) treatment on an experimental device and a commercially available device. This study will involve taking a finger-puncture and testing onto a strip and meter system for the experimental and commercially available devices.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Are currently taking coumadin (warfarin)
  • Are aged 18 years or older
  • Able and willing to provide informed consent
  • Can understand (read and write) English
  • Required to provide a capillary sample as part of their routine medical check

排除标准

  • Previously participated in this study

结局指标

主要结局

PT/INR values from the experimental device will be statistically correlated to results obtained from a commercially available device

时间窗: Five days to collect data and up to two weeks to generate correlation graph

To determine the correlation of PT/INR values between an experimental and commercial device

次要结局

未报告次要终点

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验